Sort   by:  
 Page size 
UnknownRandomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma.
Not available
S-EPMC5569691 | biostudies-literature
UnknownHigh-throughput isolation of Caenorhabditis elegans deletion mutants.
Not available
S-EPMC310813 | biostudies-literature
UnknownHeterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant.
Not available
S-EPMC4869259 | biostudies-literature
UnknownThe oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 -) advanced/metastatic breast cancer.
Not available
S-EPMC9823088 | biostudies-literature
UnknownAnalytical Validation of a Hybrid Capture-Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA.
Not available
S-EPMC6593250 | biostudies-literature
Sort   by:  
 Page size